Author holds Boston Scientific, calls it cheap with near-term catalysts after an acquisition-driven selloff.
BSX — LONG The author holds Boston Scientific and argues it is cheap with near-term catalysts after a selloff driven by acquisition news. The mechanism is that the market overreacted to the acquisition, creating upside from current levels. No specific target or timeframe is provided.
But it’s really cheap and has near term catalysts. Recent sell off was due to acquisition news but I see a real upside from here.
This Reddit post, published January 17, 2026, features u/anonymous_sheep1 discussing BSX. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/anonymous_sheep1 · Tickers: BSX